Pfizer’s HYMPAVZI Gains FDA Approval for Expanded Hemophilia Care
NEW YORK, USA – June 8, 2026 Pfizer has secured U.S. Food and Drug Administration (FDA) approval for an...
artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology NSCLC Oncology oncology innovation Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory compliance targeted therapy
NEW YORK, USA – June 8, 2026 Pfizer has secured U.S. Food and Drug Administration (FDA) approval for an...
LONDON, United Kingdom & BOSTON, Massachusetts, USA – June 8, 2026 GSK has announced a definitive agreement to acquire...
WILMINGTON, Delaware, USA – June 8, 2026 Incyte Corporation has announced a definitive agreement to acquire Vega Therapeutics, a...
ANN ARBOR, Mich. & HENDERSON, Nev., March 3, 2026 Esperion Therapeutics and Corstasis Therapeutics Inc. announced a definitive agreement...
